Merck Ordered to Pay 14 Million in Attorneys Fees to Rival Gilead After a Patent Infringement Trial Involving Hepatitis C Drugs
Written by Mark Speegle and Sean Murray Edited by John Sganga , Joseph Cianfrani , and Boris Zelkind On July 14, 2017, in a stunning reversal of fortune, a federal court in San Jose, CA, which had previously set aside a $200 million jury verdict in favor…





